Relationships between Nighttime Imagery and Population Density for Hong Kong

Nighttime imagery is an unusual remote sensing data source that offers capabilities to represent human activities on the Earth’s surface through the observation of artificial lighting at night. Previous analyses of images of the earth at night derived from the Defense Meteorological Satellite Program-Operational Linescan System (DMSP-OLS) have revealed a striking correlation between city-lights and human population density. Nighttime light photographs taken by astronauts aboard the International Space Station (ISS) may have the potential of offering more sophisticated representations of population density with finer spatial and spectral resolution than the DMSP-OLS imagery. The objective of this study is to analyze and map the relationships between the city lights of Hong Kong, China, and representations of population and population density, through comparing two types of nighttime imagery (DMSP-OLS satellite image and ISS photograph) to census population and population density derived from the LandScan population dataset

Mapping the Constructed Surface Area Density for China

Efforts to map the constructed surface area density of the world using nighttime satellite imagery have typically been validated using aerial photography or high resolution satellite imagery in the United States and extrapolating regression parameters to countries outside of the United States. In a previous study, we found China to have ‘paved’ more of the planet than any other country (~87,00 km2). Here we use a google earth based web application to validate our estimates of anthropogenic impervious surface (constructed area density) in China using actual imagery of China.  ‘Paving the Planet’ is a universal phenomenon – akin to clothing – and represents one of the primary anthropogenic modifications of the environment.  Expansion in population numbers and economies combined with the increased use of automobiles has led to the sprawl of development and a wide proliferation of constructed impervious surfaces. Constructed impervious surfaces are both hydrological and ecological disturbances.  However, constructed surfaces are different from most other types of disturbances in that recovery is arrested through the use of materials that are resistant to decay and are actively maintained. The same characteristics that make impervious surfaces ideal for use in construction produce a series of effects on the environment.  We present a new map of the density of constructed surface in China derived from DMSP nighttime lights and LandScan population count data

Implications of land-grabbing on the ecological balance of Brazil

In the global free-market, natural resource scarcity and opportunities for preserving the local environment are fostering international purchasing of large extensions of land, mainly for agricultural use. These land transactions often involve land cover change (i.e., through deforestation) or a shift from extensive or traditional to intensive agricultural practices. In Brazil, the land appropriation by foreign investors (i.e., the so-called "land-grabbing") is affecting natural capital availability for local communities to a different extent in the very different territorial entities. At the same time, Brazilian investors are purchasing land in other countries. Ecological footprint accounting is one appropriate lens that can be employed to visualize the aggregated effect of natural capital appropriation and use. The aim of this paper is to provide a first estimate on the effect of land-grabbing on the ecological balance of Brazil through calculating the biocapacity embodied in purchased lands in the different states of Brazil. The results show that Brazil is losing between 9 to 9.3 million global hectares (on a gross basis, or a net total of 7.7 to 8.6 million of global hectares) of its biocapacity due to land-grabbing, when considering respectively a "cropland to cropland" (i.e., no land-cover change) and a "total deforestation" scenario. This represents a minimum estimate, highlighting the need for further land-grabbing data collection at the subnational scale. This analysis can be replicated for other countries of the world, adjusting their ecological balance by considering the biocapacity embodied in international transactions of land

Impact of program characteristics on weight loss in adult behavioral weight management interventions: systematic review and component network meta-analysis

Objective: Behavioral weight management programs (BWMPs) for adults lead to greater weight loss at 12 months than minimal-intervention control treatments. However, there is considerable heterogeneity in the content of BWMPs and outcomes of treatment. This study assessed the contribution of individual components of BWMPs, using Bayesian component network meta-analysis. Methods: Randomized controlled trials of BWMPs in adults were identified (latest search: December 2019) and arms coded for presence or absence of 29 intervention components grouped by type, content, provider, mode of delivery, and intensity. Results: A total of 169 studies (41 judged at high risk of bias) were included in the main analysis. Six components had effect estimates indicating clinically significant benefit and credible intervals (CrIs) excluding no difference: change in diet (mean difference [MD] = −1.84 kg, 95% CrI: −2.91 to −0.80); offering partial (MD = −2.12 kg, 95% CrI: −3.39 to −0.89) or total meal replacements (MD = −2.63 kg, 95% CrI: −4.58 to −0.73); delivery by a psychologist/counselor (MD = −1.45 kg, 95% CrI: −2.81 to −0.06) or dietitian (MD = −1.31 kg, 95% CrI: −2.40 to −0.24); and home setting (MD = −1.05 kg, 95% CrI: −2.02 to −0.09). Conclusions: Future program development should consider including these components; other approaches continue to warrant evaluation of effectiveness

National ecosystem service mapping approaches

The creation of any comprehensive mapping instrument at the national level requires the careful consideration of a set of issues, with components that range from the scientific to the technical and from the economic to the organisational. Wealthier countries, such as the United States and many European countries, have a long tradition of national level cartography, analogue and then digital, dating back centuries - with the first comprehensive and ‘modern’ example being the Cassini Maps of 18th century France. In the United States, the ‘National Map ’ is the digital version and the continuation of efforts to map the country at a variety of scales and for multiple purposes was started in the late 1800s by the United States Geological Survey. One of many efforts to provide national maps for the US was the ‘National Map’ which includes data layers on elevation, hydrography, geographic names, transportation, structures, boundaries, ortho-imagery and land cover. Another example, the ‘Australian National Map’, includes not only the same data layers as the U.S. national map but also layers on communication, environment, framework, groundwater, habitation, infrastructure, utility and vegetation. For the world in general, the quality and quantity of information related to ecosystems and ecosystem services (ES) has been growing and it is expected that it will continue to do so as a result of increasing awareness of our fundamental dependence on natural capital and the value of ES. In this context, national maps may function as providers of reference cartographic data (see Chapter 7.1). Action 5 of the EU Biodiversity Strategy to 2020 calls for European Union’s member states to map and assess the state of ecosystems and their services in their national territory. In the United States, a memorandum was issued in October 2015 directing Federal agencies to factor the value of ES into planning and decision-making activities at the federal level (see Chapter 7.1 for more details). The mapping of ecosystems is an essential first step in conducting an inventory of that portion of our common wealth that manifests as natural capital. In this chapter, we briefly touch - from the perspective of the mapmaker - on a small set of topics related to the national mapping of ecosystems and ES. This discussion is by no means exhaustive and additional topics may be worth reviewing. Our objective is to inform the reader and to pique his or her curiosity; for further information, vast literature exists on all of these topics

Drug discovery for male subfertility using high-throughput screening:a new approach to an unsolved problem

STUDY QUESTIONCan pharma drug discovery approaches be utilized to transform investigation into novel therapeutics for male infertility?SUMMARY ANSWERHigh-throughput screening (HTS) is a viable approach to much-needed drug discovery for male factor infertility.WHAT IS KNOWN ALREADYThere is both huge demand and a genuine clinical need for new treatment options for infertile men. However, the time, effort and resources required for drug discovery are currently exorbitant, due to the unique challenges of the cellular, physical and functional properties of human spermatozoa and a lack of appropriate assay platform.STUDY DESIGN, SIZE, DURATIONSpermatozoa were obtained from healthy volunteer research donors and subfertile patients undergoing IVF/ICSI at a hospital-assisted reproductive techniques clinic between January 2012 and November 2016.PARTICIPANTS/MATERIALS, SETTING, METHODSA HTS assay was developed and validated using intracellular calcium ([Ca2+]i) as a surrogate for motility in human spermatozoa. Calcium fluorescence was detected using a Flexstation microplate reader (384-well platform) and compared with responses evoked by progesterone, a compound known to modify a number of biologically relevant behaviours in human spermatozoa. Hit compounds identified following single point drug screen (10 μM) of an ion channel-focussed library assembled by the University of Dundee Drug Discovery Unit were rescreened to ensure potency using standard 10 point half-logarithm concentration curves, and tested for purity and integrity using liquid chromatography and mass spectrometry. Hit compounds were grouped by structure activity relationships and five representative compounds then further investigated for direct effects on spermatozoa, using computer-assisted sperm assessment, sperm penetration assay and whole-cell patch clamping.MAIN RESULTS AND THE ROLE OF CHANCEOf the 3242 ion channel library ligands screened, 384 compounds (11.8%) elicited a statistically significant increase in calcium fluorescence, with greater than 3× median absolute deviation above the baseline. Seventy-four compounds eliciting ≥50% increase in fluorescence in the primary screen were rescreened and evaluated further, resulting in 48 hit compounds that produced a concentration-dependent increase in [Ca2+]i. Sperm penetration studies confirmed in vitro exposure to two hit compounds (A and B) resulted in significant improvement in functional motility in spermatozoa from healthy volunteer donors (A: 1 cm penetration index 2.54, 2 cm penetration index 2.49; P &lt; 0.005 and B: 1 cm penetration index 2.1, 2 cm penetration index 2.6; P &lt; 0.005), but crucially, also in patient samples from those undergoing fertility treatment (A: 1 cm penetration index 2.4; P = 0.009, 2 cm penetration index 3.6; P = 0.02 and B: 1 cm penetration index 2.2; P = 0.0004, 2 cm penetration index 3.6; P = 0.002). This was primarily as a result of direct or indirect CatSper channel action, supported by evidence from electrophysiology studies of individual sperm.LIMITATIONS, REASONS FOR CAUTIONIncrease and fluxes in [Ca2+]i are fundamental to the regulation of sperm motility and function, including acrosome reaction. The use of calcium signalling as a surrogate for sperm motility is acknowledged as a potential limitation in this study.WIDER IMPLICATIONS OF THE FINDINGSWe conclude that HTS can robustly, efficiently, identify novel compounds that increase [Ca2+]i in human spermatozoa and functionally modify motility, and propose its use as a cornerstone to build and transform much-needed drug discovery for male infertility.</p

Solution structure of the inner DysF domain of myoferlin and implications for limb girdle muscular dystrophy type 2b

Mutations in the protein dysferlin, a member of the ferlin family, lead to limb girdle muscular dystrophy type 2B and Myoshi myopathy. The ferlins are large proteins characterised by multiple C2 domains and a single C-terminal membrane-spanning helix. However, there is sequence conservation in some of the ferlin family in regions outside the C2 domains. In one annotation of the domain structure of these proteins, an unusual internal duplication event has been noted where a putative domain is inserted in between the N- and C-terminal parts of a homologous domain. This domain is known as the DysF domain. Here, we present the solution structure of the inner DysF domain of the dysferlin paralogue myoferlin, which has a unique fold held together by stacking of arginine and tryptophans, mutations that lead to clinical disease in dysferlin

A new fireworm (Amphinomidae) from the Cretaceous of Lebanon identified from three-dimensionally preserved myoanatomy

© 2015 Parry et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. The attached file is the published version of the article

Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.

BACKGROUND: The behavioural impact of pharmacogenomics is untested; informing smokers of genetic test results for responsiveness to smoking cessation medication may increase adherence to this medication. The objective of this trial is to estimate the impact upon adherence to nicotine replacement therapy (NRT) of informing smokers that their oral dose of NRT has been tailored to a DNA analysis. Hypotheses to be tested are as follows: I Adherence to NRT is greater among smokers informed that their oral dose of NRT is tailored to an analysis of DNA (genotype), compared to one tailored to nicotine dependence questionnaire score (phenotype). II Amongst smokers who fail to quit at six months, motivation to make another quit attempt is lower when informed that their oral dose of NRT was tailored to genotype rather than phenotype. METHODS/DESIGN: An open label, parallel groups randomised trial in which 630 adult smokers (smoking 10 or more cigarettes daily) using National Health Service (NHS) stop smoking services in primary care are randomly allocated to one of two groups:i. NRT oral dose tailored by DNA analysis (OPRM1 gene) (genotype), orii. NRT oral dose tailored by nicotine dependence questionnaire score (phenotype)The primary outcome is proportion of prescribed NRT consumed in the first 28 days following an initial quit attempt, with the secondary outcome being motivation to make another quit attempt, amongst smokers not abstinent at six months. Other outcomes include adherence to NRT in the first seven days and biochemically validated smoking abstinence at six months. The primary outcome will be collected on 630 smokers allowing sufficient power to detect a 7.5% difference in mean proportion of NRT consumed using a two-tailed test at the 5% level of significance between groups. The proportion of all NRT consumed in the first four weeks of quitting will be compared between arms using an independent samples t-test and by estimating the 95% confidence interval for observed between-arm difference in mean NRT consumption (Hypothesis I). Motivation to make another quit attempt will be compared between arms in those failing to quit by six months (Hypothesis II). DISCUSSION: This is the first clinical trial evaluating the behavioural impact on adherence of prescribing medication using genetic rather than phenotypic information. Specific issues regarding the choice of design for trials of interventions of this kind are discussed. TRIAL DETAILS: Funder: Medical Research Council (MRC)Grant number: G0500274. ISRCTN: 14352545. Date trial stated: June 2007. Expected end date: December 2009. Expected reporting date: December 2010.RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'. In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are